Home · Open Lab · Lot RGX-26-MELANOTAN-642
RGX-26-MELANOTAN-642Superseded
Melanotan-2 · 10 MG · Dermal Research · COA NS-2026-05192

Release test results

99.572%HPLC purity · meets ≥ 99.5% spec
Mass-spec identityConfirmed · 10.06 mg
Related impurities (total)0.428%
Endotoxin<1.0 EU/mg
HPLC retention time7.79 min
MethodHPLC + LC-MS
ResultPass · meets spec
Verify COA at Nordicstar Labs → All certificates

Lot record

CompoundMelanotan-2
Presentation10 MG
Lot numberRGX-26-MELANOTAN-642
COA numberNS-2026-05192
Test date02 Sep 2026
Release date05 Sep 2026
Independent labNordicstar Labs
StatusSuperseded

Melanotan-2 — lot history

LotPresentationTestedHPLC purityStatus
RGX-26-MELANOTAN-74210 MGSep 7, 202699.755%Superseded
RGX-26-MELANOTAN-105810 MGSep 6, 202699.699%Current
RGX-26-MELANOTAN-642 this lot10 MGSep 2, 202699.572%Superseded
!
Research use only

This lot record documents a research compound sold for laboratory use only — not for human or animal consumption. Results are as tested by Nordicstar Labs; retained samples are archived for five years. Research Use Agreement →